drugset / Trial / NCT02380742

Topical Anesthetic Use In Pessary Management

NCT02380742

Phase 2 Completed 54 enrolled Loyola University
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate if lidocaine-prilocaine (EMLA 5%) cream can reduce pain and discomfort at the time of vaginal pessary removal and insertion. Half of the participants will receive lidocaine-prilocaine (EMLA 5%) cream and the other half will receive a placebo cream.

Timeline

Start
2015-07
Primary completion
2016-02
Completion
2016-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine-Prilocaine Unknown 4 ml Topical

Indications

No indication recorded.